English version | Version Française
  ISSUE No. 64
Editorial

Dear Valued Investors,

The April edition of our newsletter focuses on biotechnology and it highlights the potential that it represents for our economy.

Indeed biotechnology has revolutionized the delivery of healthcare services, the development of alternative energy sources...

Read More »



Mauritius steps into the biotech era with BioAfrica 2014

Over the years, Mauritius has made significant strides towards the development of biotech applications and this has led to the emergence of a nascent biotech industry...

Read More »

Interview of Dr. Rashmi Barbhaiya, CEO, Advinus Therapeutics, TATA Group, India

My doctorate degree is in the field of clinical pharmacology which I studied in England. I have spent 21 years at Bristol Myers Squibb in USA.

Read More »
Interview of Professor Ameenah Gurib-Fakim, Managing Director, Cephyr

I have been working in this field for over 20 years now. With a strong background in organic chemistry, I wanted to pursue research in this area when I returned to Mauritius from the UK where I studied.

Read More »

OECD rates Mauritius as a ‘Largely Compliant’ jurisdiction

In line with the international movement towards more transparency and exchange of information, Mauritius has...

Read More »

Mines and Money Access Africa Mauritius 2014

Where African mining projects access Asian and global capital...

Read More »


Editorial Team: Ken Poonoosamy, Shamima Mallam-Hassam, Harvesh Seegolam, Haliima Soreefan
Contributors: Nitin Pandea, Sachin Mohabeer, Pratima Sewpal, Umeir Soodhun, Hanzy Mundil, Anju Bundhoo
Special Thanks: Guy David